News

Cardinal Health announced an agreement to acquire privately held AccessClosure Inc. for $320 million.

Home April 08, 2014
Home
SCAI ACC.14 Choosing Wisely Campaign Tests Treatments to Avoid Cath Lab
Feature

The Society for Cardiovascular Angiography & Interventions (SCAI) issued a list of five specific, evidence-based recommendations that should be avoided in the care of patients who have, or are at risk for, cardiovascular disease.

Home April 08, 2014
Home
Philips CT, cardiac CTA, calcium scoring, ACC.14
Feature

Coronary artery calcium scoring, a test that measures the amount and pattern of calcium that has accumulated in a patient’s coronary arteries, appears to provide an early indication of a person’s long-term risk for heart disease, according to data from five studies presented at the American College of Cardiology (ACC) 63rd Annual Scientific Session.

Home April 08, 2014
Home
News

Philips Healthcare presented new imaging and informatics solutions at the American College of Cardiology Conference (ACC) Annual Meeting.

Home April 08, 2014
Home
News

GE Healthcare showcased a new suite of connected cardiovascular technologies, including several for advanced imaging and new software capabilities, at ACC 2014. New innovations included advances in molecular diagnostics, super-speed computed tomography (CT) scans, and patient-friendly electrocardiograms.

Home April 08, 2014
Home
ICD, MADIT-CRT trial, long-term followup, ACC.14
Feature | Implantable Cardioverter Defibrillator (ICD) | Dave Fornell

Patients in mild heart failure who receive a cardiac resynchronization therapy defibrillator (CRT-D) device may live longer than those implanted with a traditional implantable cardioverter defibrillator (ICD), according to research presented at the American College of Cardiology’s 63rd Annual Scientific Session.

Home April 08, 2014
Home
ICD pic 2
Feature | Richard Chang, M.D., Cor Cardiovascular Specialists

I had become accustomed to making the necessary tradeoffs when choosing the appropriate defibrillator for my patients and until recently thought that these choices were ones that I would always have to make. But the options have increased and matching the unique capabilities of devices, lead systems and remote monitoring has become easier now that there are more than two distinct categories of defibrillator systems available — single and double lead implants and now, the DX system.

Home April 07, 2014
Home
Merge, CVIS, cardiac PACS
Feature | Bob Schallhorn

Patients do not have to be the only beneficiaries of technological innovation. Indeed, many technological hardware and software solutions are emerging to help cardiac care providers negotiate their way through a healthcare environment that’s increasingly competitive, cost-conscious and challenging.

Home April 07, 2014
Home
Feature | Dave Fornell

Congress recently passed the Protecting Access to Medicare Act of 2014, which requires use of appropriate use criteria (AUC) and clinical decision support (CDS) software to get Medicare reimbursement. This will likely shift focus onto IT vendors who can supply this software. In addition, the use of CDS is part of Stage 2 Meaningful Use requirements for electronic medical records (EMR), so the new Medicare requirements will move CDS up on many IT departments' priority lists.

Home April 07, 2014
Home
IV in arm_iStock_495949Medium
Feature

In a comparison of two blood-thinning medications, heparin was associated with significantly fewer major cardiovascular events at 28 days than bivalirudin in patients receiving primary percutaneous coronary intervention (PCI) after a heart attack, according to research presented at the American College of Cardiology’s 63rd Annual Scientific Session.

Home April 07, 2014
Home
Technology

Epsilon Imaging Inc. has expanded its EchoInsight automated measurement suite for improved analysis and interpretation in echo.

Home April 07, 2014
Home
TAVI Corevalve _from Philips hybrid OR PR
Feature

April 7, 2014 — A first-ever randomized head-to-head comparison of two devices commonly used to treat aortic stenosis finds balloon-expandable transcatheter valves (such as the Edwards Sapien) result in more successful procedures and relieve symptoms more frequently than self-expanding valves (e.g., Medtronic CoreValve), according to research presented at ACC.14.

Home April 07, 2014
Home
hospital_ward_iStock_000000430101Large_1
Feature

April 7, 2014 — Strategies aimed at reducing the number of patients with heart failure and other cardiovascular conditions who find themselves back in the hospital after discharge were identified in six new studies presented at the American College of Cardiology (ACC) 63rd annual scientific session.

Home April 07, 2014
Home
Medtronic, SYMPLICITY, SYMPLICITY HTN-3 trial, renal denervation, ACC.14
Feature | Hypertension | Dave Fornell

A major disappointment earlier this year was the announcement by Medtronic that its renal denervation system failed to meet its primary endpoint for efficacy in the U.S. SYMPLICITY HTN-3 trial. This trial data was presented to a packed, standing-room only crowd of several thousand cardiologists at the American College of Cardiology (ACC) 63rd annual scientific session in March. These attendees also sought more information and a glimmer of hope for the technology at the presentation of data from the Global SYMPLICITY registry and numerous sessions on renal denervation technology.

Home April 04, 2014
Home
Iodixanol Iopamidol Contrast Media Peripheral Arteriography ACC.14 Clinical Stud
Feature

GE Healthcare announced results from a new clinical study, which showed that patients receiving iodixanol (Visipaque) 320mg I/ml reported less discomfort, characterized by heat or cold sensation or pain upon injection, than patients receiving iopamidol (Isovue) 370 mg I/ml during peripheral arteriography.

Home April 04, 2014
Home
Subscribe Now